Table 2.

Descriptive analysis results

Variables	Baseline						4-month follow-up
	Patient			Partner			Patient			Partner
	N	Mean	SD	N	Mean	SD	N	Mean	SD	N	Mean	SD
Quality of life1	134	85.20	13.09	134	85.63	11.87	124	84.95	12.39	124	83.82	13.07
Social support1	134	88.18	12.12	134	85.24	14.25	124	86.69	13.13	124	84.52	15.12
Uncertainty2	134	60.54	15.53	134	61.84	16.05	124	60.31	17.16	124	62.90	16.91
Levels of dyadic communication1	130	3.72	.66	132	3.70	.63	120	3.63	.73	122	3.51	.78
Pca-specific symptoms_urine1	133	77.29	16.01	134	4.08	1.18	124	81.19	15.85	124	4.18	1.13
Pca-specific symptoms_bowel1	131	88.71	12.01	134	4.58	.87	122	90.05	12.73	124	4.65	.82
Pca-specific symptoms_sexual1	130	26.76	21.92	132	3.30	1.49	123	29.13	23.04	123	3.16	1.60
PCa-specific symptoms_hormonal1	134	82.16	15.01	134	4.08	1.19	124	83.09	15.13	124	4.07	1.27
General symptom score2	134	7.07	4.35	134	5.50	3.82	124	6.43	4.24	124	6.23	4.48

Variables	8-month follow-up						12-month follow-up						F ratio (df=3)
	Patient			Partner			Patient			Partner			Patient	Partner
	N	Mean	SD	N	Mean	SD	N	Mean	SD	N	Mean	SD	Time Effect	Time Effect
Quality of life1	122	86.54	12.83	122	83.85	14.27	114	86.52	12.60	119	84.01	14.93	.54	.54
Social support1	122	86.99	12.02	122	83.98	14.41	114	87.34	13.50	119	84.10	16.05	.34	.19
Uncertainty2	122	58.78	14.91	121	61.66	16.98	114	57.08	15.62	114	59.95	16.69	1.23	.63
Levels of dyadic communication1	119	3.73	.64	120	3.50	.73	111	3.64	.68	116	3.45	.76	.77	2.93*
Pca-specific symptoms_urine1	120	82.79	14.15	121	4.22	1.10	113	83.57	13.93	114	4.30	1.05	4.34**	.81
Pca-specific symptoms_bowel1	120	89.96	12.39	121	4.62	.82	112	90.63	11.13	114	4.61	.82	.55	.16
Pca-specific symptoms_sexual1	119	29.53	23.65	120	3.23	1.57	112	32.43	24.49	112	3.21	1.58	1.20	.18
PCa-specific symptoms_hormo1	122	85.02	14.53	120	4.12	1.20	111	85.71	13.75	114	4.07	1.17	1.55	.04
General symptom score2	122	6.30	4.55	122	6.19	4.31	114	5.82	4.08	119	6.04	4.55	1.76	.81

¹Higher scores indicate more positive results: better QOL, more communication, more support from others, and less Pca-specific symptoms

²Higher scores indicate more negative results: more uncertainty about the illness and more symptom distress such as fatigue, nausea, and difficulty sleeping

^*P < .05;

^**P < .001